In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Pfizer to co-promote W-L lipid drug atorvastatin

Executive Summary

Pfizer will co-promote for 10 years Warner-Lambert's Lipitor (atorvastatin), an anti-cholesterol, HMG CoA reductase inhibitor with more powerful LDL reduction than other statins as well as a unique-for-statins claim of triglycerides reduction.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Co-Promotion
    • Includes Contract
    • Marketing (Licensing)
    • Product or Technology Swap

Related Companies